Cargando…

Clozapine Management in Schizophrenia Inpatients: A 5-Year Prospective Observational Study of Its Safety and Tolerability Profile

BACKGROUND: Clozapine is well known for its efficacy and clinical superiority compared to other antipsychotics in treatment-resistant schizophrenia (TRS). However, it is frequently underutilized worldwide because of its acute adverse events, as well as for its long-term cardiometabolic and hematolog...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Filippis, Renato, Gaetano, Raffaele, Schoretsanitis, Georgios, Verde, Giuseppe, Oliveti, Cesare Anthony, Kane, John M, Segura-Garcia, Cristina, De Fazio, Pasquale
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257059/ https://www.ncbi.nlm.nih.gov/pubmed/34234440 http://dx.doi.org/10.2147/NDT.S312095

Ejemplares similares

Co-occurrence of clozapine-related DRESS syndrome core clinical manifestations: results of a systematic review
por: De Filippis, R., et al.
Publicado: (2022)

Tolerability profile of paliperidone palmitate formulations: A pharmacovigilance analysis of the EUDRAVigilance database
por: Cicala, Giuseppe, et al.
Publicado: (2023)

Machine learning techniques in a structural and functional MRI diagnostic approach in schizophrenia: a systematic review
por: de Filippis, Renato, et al.
Publicado: (2019)

Rare and very rare adverse effects of clozapine
por: De Fazio, Pasquale, et al.
Publicado: (2015)

An international clozapine titration guideline to increase its safety and move forward on the route started by German-speaking psychiatrists in the 1960s
por: de Leon, Jose, et al.
Publicado: (2022)

Promoting safer clozapine dosing in the Americas
por: de Leon, Jose, et al.
Publicado: (2022)

Aberrant salience correlates with psychotic dimensions in outpatients with schizophrenia spectrum disorders
por: Pugliese, Valentina, et al.
Publicado: (2022)

Clozapine once- versus multiple-daily dosing: a two-center cross-sectional study, systematic review and meta-analysis
por: Kuzo, Nazar, et al.
Publicado: (2022)

Lower sertraline plasma concentration in patients co‐medicated with clozapine—Implications for pharmacological augmentation strategies in schizophrenia
por: Gaebler, Arnim Johannes, et al.
Publicado: (2023)

Treatment of Hypochondriasis in Two Schizophrenia Patients Using Clozapine
por: Tundo, Antonio, et al.
Publicado: (2017)

Clozapine & constipation: an audit of bowel habit monitoring and laxative prescribing in inpatients on clozapine
por: Boyd, Holly, et al.
Publicado: (2021)

Efficacy and Tolerability of Clozapine versus Quetiapine in Treatment-resistant Schizophrenia
por: Kumar, Mitesh, et al.
Publicado: (2017)

Application of Support Vector Machine on fMRI Data as Biomarkers in Schizophrenia Diagnosis: A Systematic Review
por: Steardo, Luca, et al.
Publicado: (2020)

Use of Long-Acting Injectable Antipsychotics in Inpatients with Schizophrenia Spectrum Disorder in an Academic Psychiatric Hospital in Switzerland
por: Reymann, Stephan, et al.
Publicado: (2022)

Clozapine Response in Schizophrenia and Hematological Changes
por: Blackman, Graham, et al.
Publicado: (2021)

USE OF CLOZAPINE IN CHILDHOOD SCHIZOPHRENIA
por: Srinivasan, T.N., et al.
Publicado: (1997)

In the aftermath of clozapine discontinuation: comparative effectiveness and safety of antipsychotics in patients with schizophrenia who discontinue clozapine
por: Luykx, Jurjen J., et al.
Publicado: (2020)

An international guideline with six personalised titration schedules for preventing myocarditis and pneumonia associated with clozapine
por: de Leon, Jose, et al.
Publicado: (2022)

A False Case of Clozapine-Resistant Schizophrenia
por: Maia-de-Oliveira, J. P., et al.
Publicado: (2010)

Clozapine is underutilized
por: Kane, John M.
Publicado: (2012)

Effectiveness of SGA-LAIs on Clinical, Cognitive, and Social Domains in Schizophrenia: Results from a Prospective Naturalistic Study
por: de Filippis, Renato, et al.
Publicado: (2023)

Do Asian Patients Require Only Half of the Clozapine Dose Prescribed for Caucasians? A Critical Overview
por: de Leon, Jose, et al.
Publicado: (2020)

Effectiveness of clozapine in treatment-resistant schizophrenia
por: Raguraman, Janakiraman, et al.
Publicado: (2005)

Clozapine: Improvement of Negative Symptoms of Schizophrenia
por: Khan, Afaque H, et al.
Publicado: (2017)

Clozapine discontinuation withdrawal symptoms in schizophrenia
por: Blackman, Graham, et al.
Publicado: (2021)

Management of patients with Clozapine Resistant Schizophrenia
por: Rajendran*, Nithya Ragavi, et al.
Publicado: (2022)

The Utilisation Rate of Clozapine for Treatment Resistant Schizophrenia Within Trustwide Adult Inpatient Services Over One Year
por: Zhang, Peter, et al.
Publicado: (2023)

Difference between treatment-resistant schizophrenia and clozapine-resistant schizophrenia
por: Tseng, Ping-Tao, et al.
Publicado: (2022)

Clozapine- and non-clozapine-associated neutropenia in patients with schizophrenia: a retrospective cohort study
por: Johannsen, Claas-Frederik, et al.
Publicado: (2022)

Clozapine Reverses Dysfunction of Glutamatergic Neurons Derived From Clozapine-Responsive Schizophrenia Patients
por: Hribkova, Hana, et al.
Publicado: (2022)

REFRACTORY SCHIZOPHRENIA, CLOZAPINE AND EPILEPSY : MANAGEMENT STRATEGIES
por: Guha, Prathama, et al.
Publicado: (1998)

AN OPEN STUDY OF CLOZAPINE IN THE TREATMENT OF RESISTANT SCHIZOPHRENIA
por: Desai, Neena, et al.
Publicado: (1999)

Combination of ECT and clozapine in drug-resistant schizophrenia
por: Kurian, S., et al.
Publicado: (2005)

Homocysteine Levels in Patients with Schizophrenia on Clozapine Monotherapy
por: Wysokiński, Adam, et al.
Publicado: (2013)

Glutamatergic Neurometabolites in Clozapine-Responsive and -Resistant Schizophrenia
por: Goldstein, Meghan Elizabeth, et al.
Publicado: (2015)

Clozapine Pharmacogenetic Studies in Schizophrenia: Efficacy and Agranulocytosis
por: Numata, Shusuke, et al.
Publicado: (2018)

Clozapine resistant schizophrenia: Newer avenues of management
por: Chakrabarti, Subho
Publicado: (2021)

Cariprazine — an Alternative Treatment for Clozapine-resistant Schizophrenia?
por: Montgomery, Adam, et al.
Publicado: (2023)

A case report—“When less is more”: controlled inpatient reduction of anticholinergic burden in a patient with clozapine-resistant schizophrenia
por: Pjevac, Milica, et al.
Publicado: (2023)

Long-term treatment with clozapine and verbal memory performance in schizophrenia
por: Czepielewski, Letícia S., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_e4n3jhg8get7r9cjd0jjo2mq0h